Chemokine receptor antagonists and methods of use therefor
US6503926B2 · kind B2 · utility
15Cited by
10References
37Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 28, 1999 |
| Grant date | Jan 7, 2003 |
| Priority date | — |
| Expiry date | Jul 28, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: and physiologically acceptable salts thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.